VERBINDUNGEN

European patent · EP3810633 · In force

Register entry

Publication number
EP3810633
Application number
EP19734346
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 25, 2019
Published
Apr 28, 2021
Granted
Dec 13, 2023
Protection ends at the latest
Jun 24, 2039
Next annual fee due
Jun 30, 2026
IPC classes
C07K 7/62 (2006.01)
A61K 38/12 (2006.01)
Priority
US 201862689602 P 25.06.2018
PCT application
PCT/EP2019/066819 25.06.2019
PCT publication
WO2020/002325 02.01.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2025

    Change

    Published in Swissreg on 01.07.2025

  2. Oct 23, 2024

    Change

    Published in Swissreg on 23.10.2024

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Dec 14, 2023

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  5. Dec 13, 2023

    Granted

    Published in Swissreg on 13.12.2023

Parties

Holder

Spero Therapeutics, Inc.

675 Massachusetts Avenue 14th Floor, Cambridge, Massachusetts 02139, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

RIVERS, Dean

Reading, Berkshire RG1 9LS, GB

DAWSON, Michael

Reading, Berkshire RG1 9LS, GB

COLEMAN, Scott

Cambridge, Massachusetts 02139, US

BOAKES, Steven

Reading, Berkshire RG1 9LS, GB

SIMONOVIC, Mona

Reading, Berkshire RG1 9LS, GB

DUPERCHY, Esther

Reading, Berkshire RG1 9LS, GB

BROWN, Pamela

Reading, Berkshire RG1 9LS, GB

LESTER, Roy

Reading, Berkshire RG1 9LS, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.